MMD vs XCBE
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
MMD presents a high-risk profile characterized by a stable Piotroski F-Score of 5/9 but severe valuation disconnects. The current price of $14.88 trades at a massive premium to both the Graham Number ($6.08) and the Intrinsic Value ($1.51). Financial stability is undermined by a catastrophic dividend payout ratio of 720%, indicating that distributions are not supported by earnings. Combined with negative revenue growth (-15%) and a bearish technical trend (0/100), the fund appears fundamentally overvalued.
XCBE exhibits critical financial weakness, highlighted by a Piotroski F-Score of 2/9, placing it firmly in the 'Weak' health category. As a shell company, it lacks operational revenue and earnings, but more concerning is the extreme liquidity crisis indicated by a Current Ratio of 0.04 and a deeply negative Price/Book ratio of -1237.50. The absence of an Altman Z-Score and Graham Number reflects a lack of traditional fundamental value. The stock is currently trading near its 52-week high, likely reflecting the trust value of a SPAC rather than business performance.
Compare Another Pair
Related Comparisons
MMD vs XCBE: Head-to-Head Comparison
This page compares NYLI MacKay DefinedTerm Muni Opportunities Fund (MMD) and X3 Acquisition Corp. Ltd. (XCBE) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.